Plastic Surgery Integumentary System Market Trends

Plastic Surgery and Integumentary System Procedures Market Overview

Plastic Surgery & Integumentary System Procedures Market Size was valued at USD 2.57 Billion in 2023. The Plastic Surgery & Integumentary System Procedures industry is projected to grow from USD 2.70 Billion in 2024 to USD 4.78 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.84% during the forecast period (2024 - 2032).

Plastic Surgery is a medical procedure to restore, reconstruct, or alter skin on any part of the human body. It is executed as a reconstructive and aesthetic technique. Skilled reconstructive surgeons help to improve and give back the functional impairment of the body parts instigated due to congenital defects, injury, and cancers. The aesthetic surgery discovers its claim in changing the appearance of any body part.

The integumentary system is an organ framework including skin and its extremities which safeguards the body from different sorts of damages, for example, the scraped spot from an outside element. The procedure is suggested for infection, sunburn, rash, acne, psoriasis, rubella, athlete’s foot, rabies, herpes, and skin cancer.

According to the plastic surgery statistics released by the International Society of Aesthetic and Plastic Surgery (ISAPS), in June 2019, the growth in surgical procedures displays the rising potential in the global market of plastic surgery. The rise in popularity of digital photography, an increasing number of qualified service providers, and self-monitoring apps are the factors that boost the market. Furthermore, the low cost of surgical procedures, increasing safety of surgical procedures, rising demand by customers to boost self-esteem, and growth in medical tourism help to drive the market exponentially. However, the risks associated are the competition from medical clinics which offers facial rejuvenation procedures and lack of awareness. Sociological and physiological factors such as gender, marital status, media, age, and depression are determined as factors affecting the market inversely by lowering induvial determination to undergo surgery.

Plastic Surgery and Integumentary System Procedures Market Segment Insights

The global plastic surgery and integumentary system procedures market has been segmented on the basis of procedure, operating area, application, and end-user.

On the basis of procedure, the market has been classified as prefilled syringe biopsy, excisional biopsy, incisional biopsy, Culture and Sensitivity (C&S), and skin tests.

On the basis of operating area, the market has been classified into eyelids, subcutaneous tissue, breast, nose, and skin.

On the basis of application, the market has been classified into skin grafts, allograft, autograft, infection, athlete’s foot, skin cancer, and augmentation.

On the basis of end-user, the market has been classified into hospitals and clinics, research laboratories, and research institutes.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European plastic surgery and integumentary procedures system market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The plastic surgery and integumentary system procedures market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The plastic surgery and integumentary system procedures market in the Middle East and Africa has been segmented into the Middle East and Africa.

Plastic Surgery and Integumentary System Procedures Market Regional Market Summary

In the plastic surgery and integumentary system procedures market, North America is anticipated to account for the largest market share and will continue to dominate its top position over the forecast period due to the early adoption of advanced medical technologies, increased awareness about the surgical procedures, increase in strength of senior population and changing lifestyle of people, highest expenditure on healthcare sector by government sectors, and increasing demand for cosmetic procedures.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of surgeries due to changing lifestyles is contributing to the growth of the market in this region.The market share in the Asia-Pacific region is also projected to experience the fastest growth in the near future owing to the improving healthcare infrastructure, high access to technology, budding medical tourism, and availability of high-quality services.The market in the Middle East and Africa is expected to account for the smallest share of the global plastic surgery and integumentary system procedures market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Plastic Surgery and Integumentary System Procedures Market Key Players

Some of the key players in the global Plastic Surgery and Integumentary System Procedures Market 

• Allergen Inc.


• Cynosure Inc. 


• Alma Lasers


• Lumenis


• Galderma


• Merz Pharma


• Allergan 


• Valeant Pharmaceuticals


• Sanofi 


• Integra Lifesciences


• Scivision Biotech Inc

Global Plastic Surgery and Integumentary System Procedures Market Segmentation

Global Plastic Surgery and Integumentary System Procedures Procedure Outlook

• Prefilled Syringe Biopsy


• Excisional Biopsy


• Incisional Biopsy


• Culture and Sensitivity (C&S)


• Skin Tests

Global Plastic Surgery and Integumentary System Procedures Operating Area Outlook

• Eyelids


• Subcutaneous Tissue


• Breast


• Nose


• Skin

Global Plastic Surgery and Integumentary System Procedures Applicatio Outlook

• Skin Grafts


• Allograft


• Autograft


• Infection


• Athlete’s Foot


• Skin Cancer


• Augmentation

Global Plastic Surgery and Integumentary System Procedures End-Use Outlook

• Hospitals and Clinics


• Research Laboratories


• Research Institutes

Global Plastic Surgery and Integumentary System Procedures Regional Outlook

• Americas


• North America


• US


• Canada


• South America


• Europe


• Western Europe


• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe


• Eastern Europe


• Asia-Pacific


• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific


• The Middle East & Africa


• Middle East


• Africa

Company Profiles

• Allergen Inc.


• Cynosure Inc.


• Alma Lasers


• Lumenis


• Galderma


• Merz Pharma


• Valeant Pharmaceuticals


• Sanofi


• Integra Lifesciences


• Scivision Biotech Inc.


• Others

Intended Audience

• Plastic Surgery & Integumentary System Procedures service providers


• Biotechnology Companies


• Research Institutes


• Research and Development (R&D) Companies


• Government Research Laboratories


• Dermatology Companies


• Research and Consulting Companies


• Plastic Surgery & Integumentary System Procedures Product Manufacturers and Distributors